Wow I did not know Gissi 2 was null for both tPA vs SK, and for combined use of ASA and UFH. Using UFH and tPA were considered standard of care during early parts of my training.
Look forward to your review of ISIS 3, and how it compares to, and perhaps subtly contrasts, the results here.
A reminder that it is always a good practice to read original trial that changes way we treat patients
Wow I did not know Gissi 2 was null for both tPA vs SK, and for combined use of ASA and UFH. Using UFH and tPA were considered standard of care during early parts of my training.
Look forward to your review of ISIS 3, and how it compares to, and perhaps subtly contrasts, the results here.